Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Mulshine

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
American Journal of Public Health|September 13, 2018
One Screening for Ischemic Heart Disease, Lung Cancer, and Chronic Obstructive Pulmonary Disease: A Systems Biology Bridge for Tobacco and Radiation ExposureJames L Mulshine
The Lancet. Oncology|February 2, 2015
Lung cancer screening with low-dose CT: more questions than answers--author's replyJames L Mulshine
Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Epithelial-directed drug delivery: influence of formulation and delivery devicesJames L Mulshine, Len Neckers
Clinical Lung Cancer|November 5, 2003
The potential contributions of chronic inflammation to lung carcinogenesisSantiago Ballaz, James L Mulshine
PPAR Research|March 12, 2009
Combination Therapy of PPARgamma Ligands and Inhibitors of Arachidonic Acid in Lung CancerJordi Tauler, James L Mulshine
Current Opinion in Pharmacology|July 3, 2009
Lung cancer and inflammation: interaction of chemokines and hnRNPsJordi Tauler, James L Mulshine
JAMA Oncology|October 21, 2021
The Long, Slow Road to Lung Cancer CureJames L Mulshine, Bruce Pyenson
Clinical Imaging|June 18, 2021
Thoracic CT screening: using routinely detectable COPD informationAlbert Rizzo, James L Mulshine
Oncology (Williston Park, N.Y.)|May 27, 2014
Tobacco control since the 1964 Surgeon General's Report: reflecting back and looking forwardJames L Mulshine, Cheryl Healton
Translational Lung Cancer Research|March 26, 2015
Lung cancer screening guidelines: common ground and differencesSwati Gulati, James L Mulshine
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
American Journal of Public Health|September 13, 2018
One Screening for Ischemic Heart Disease, Lung Cancer, and Chronic Obstructive Pulmonary Disease: A Systems Biology Bridge for Tobacco and Radiation ExposureJames L Mulshine
The Lancet. Oncology|February 2, 2015
Lung cancer screening with low-dose CT: more questions than answers--author's replyJames L Mulshine
Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Epithelial-directed drug delivery: influence of formulation and delivery devicesJames L Mulshine, Len Neckers
Clinical Lung Cancer|November 5, 2003
The potential contributions of chronic inflammation to lung carcinogenesisSantiago Ballaz, James L Mulshine
PPAR Research|March 12, 2009
Combination Therapy of PPARgamma Ligands and Inhibitors of Arachidonic Acid in Lung CancerJordi Tauler, James L Mulshine
Current Opinion in Pharmacology|July 3, 2009
Lung cancer and inflammation: interaction of chemokines and hnRNPsJordi Tauler, James L Mulshine
JAMA Oncology|October 21, 2021
The Long, Slow Road to Lung Cancer CureJames L Mulshine, Bruce Pyenson
Clinical Imaging|June 18, 2021
Thoracic CT screening: using routinely detectable COPD informationAlbert Rizzo, James L Mulshine
Oncology (Williston Park, N.Y.)|May 27, 2014
Tobacco control since the 1964 Surgeon General's Report: reflecting back and looking forwardJames L Mulshine, Cheryl Healton
Translational Lung Cancer Research|March 26, 2015
Lung cancer screening guidelines: common ground and differencesSwati Gulati, James L Mulshine
Pageof 9